Cancer – AOST1421: Phase 2 Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody ch14.18 in Combination with Sargramostim in Patients with Recurrent Osteosarcoma
Condition or Therapy:
Cancer and Blood Disorders
Study Number: AOST1421
What is the goal of this study?
This study assesses how well dinutuximab works in combination with sargramostim in patients with recurrent osteosarcoma.
Who can join the study?
This study may be a good fit for children and young adults who:
- are up to 29 years old and
- have been diagnosed with osteosarcoma.
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.